JXSL1600075 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Import Drug Application | 2016-12-30 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-12-20 | view |
JXSL1800049 | 输注用无菌冻干粉Telisotuzumab Vedotin | telisotuzumab vedotin | Lyophilized | Biological Products | Import Drug Application | 2018-11-15 | AbbVie Inc. | Abbvie Inc | In Review | 2018-11-14 | view |
JXHS2000004 | 维奈克拉片 | Venetoclax | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-01-13 | AbbVie Inc. | Abbvie Inc;Abbvie Ireland Nl BV | Certificate Issued | 2020-12-08 | view |
JXHS2000003 | 维奈克拉片 | Venetoclax | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-01-13 | AbbVie Inc. | Abbvie Inc;Abbvie Ireland Nl BV | Certificate Issued | 2020-12-08 | view |
JXHS2000002 | 维奈克拉片 | Venetoclax | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-01-13 | AbbVie Inc. | Abbvie Inc;Abbvie Ireland Nl BV | Certificate Issued | 2020-12-08 | view |
JYHB1501395 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-09-28 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-07-25 | view |
JYHB1500411 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-04-10 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-05-31 | view |
JYHB1400912 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2014-07-25 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-01-27 | view |
JYHB1700867 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2017-06-19 | AbbVie Inc. | Abbvie Inc | Filed | 2017-09-12 | view |
JYHB1601611 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2016-12-06 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-05-12 | view |
JYHB1700852 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2017-06-16 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-11-07 | view |
JYHB1501553 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-11-04 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-06-28 | view |
JYHB1701334 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2017-10-26 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2018-03-19 | view |
JYHB1500712 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-05-25 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-07-18 | view |
JXSL1500051 | 注射用ABT-414 | depatuxizumab mafodotin | Lyophilized | Biological Products | Import Drug Application | 2015-09-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-04-06 | view |
JXSL1500053 | 注射用ABT-414 | depatuxizumab mafodotin | Lyophilized | Biological Products | Import Drug Application | 2015-09-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-04-06 | view |
JXHL2000184 | Venetoclax片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-07-06 | AbbVie Inc. | Abbvie Inc | In Review | 2020-07-04 | view |
JXHL2000186 | Venetoclax片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-07-06 | AbbVie Inc. | Abbvie Inc | In Review | 2020-07-04 | view |
JXHL2000185 | Venetoclax片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-07-06 | AbbVie Inc. | Abbvie Inc | In Review | 2020-07-04 | view |
JXHL1600138 | Veliparib胶囊 | veliparib | Capsule | Chemical Drugs(1) | Import Drug Application | 2016-11-30 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-05-22 | view |